HerbalPlus: Immunity Claims, Subscription Trust and Growth Options
HerbalPlus sells a THB 690 herbal immunity supplement through Facebook, TikTok and 1,200 pharmacies. Revenue is THB 480 million; 18% comes from a 'subscribe and save' plan that renews automatically after a seven-day trial and requires a phone call to cancel. The label says 'clinically proven to boost immunity in 14 days', based on an uncontrolled 40-person study the founder commissioned; Thai rules treat the product as a food supplement and restrict disease or immunity claims. A paid mom-influencer campaign is planned for the back-to-school season. Growth has stalled at 6%, and the board is considering (a) a hospital partnership with co-branded packs, (b) entry into Vietnam, and (c) raising ad spend by 30%. The legal team has not reviewed claims since 2023; complaints to the call centre about cancellation rose from 2% to 9% of subscribers.
1. Assess the claim 'clinically proven to boost immunity in 14 days' for substantiation, regulatory and reputational risk. Rewrite it into defensible copy and list the evidence you would need.
Read the worked answer
Substantiation. 'Clinically proven' is an efficacy claim requiring a controlled, adequately powered, preferably pre-registered trial in the final product and target population, with an outcome that directly supports the wording. A 40-person uncontrolled 14-day study cannot establish causation; without a control arm, regression to the mean and placebo effects explain changes.
Regulatory risk. Thai rules treat the product as a food supplement and restrict disease and immunity claims. 'Boost immunity in 14 days' is borderline at best and likely non-compliant without an approved nutrient-content claim and substantiation dossier.
Reputational risk. The claim is amplified by mom influencers targeting parents, while cancellation complaints have already risen from 2% to 9%. That combination invites regulator and media scrutiny.
Defensible rewrite. 'Contains vitamin C and zinc, which contribute to the normal function of the immune system' - but only if the doses support the permitted claim and legal approves the exact wording.
Evidence needed. A product-specific randomized controlled trial or well-controlled human study with immune markers, dose justification, safety data, a claims-substantiation file and documented legal sign-off. Remove 'clinically proven' and 'in 14 days' unless a trial directly supports that timeframe.
2. Evaluate the three growth options using explicit criteria and a risk lens. Recommend one, with conditions.
Read the worked answer
Use five criteria: regulatory and legal risk, fit with brand and capabilities, capex and payback, speed to market, and downside if the option fails.
(a) Hospital partnership: moderate regulatory risk because hospital endorsement amplifies any claim, but it can build credibility and pharmacy pull. It requires the claims fix first.
(b) Vietnam entry: high market-entry cost, separate registration, no brand awareness and the same claims weakness travels. It has the highest downside and the slowest payback.
(c) +30% ad spend: fastest to execute, but it pours money into a funnel with 9% cancellation complaints and unreviewed claims. Incremental CAC is likely poor and the trust problem worsens.
Recommendation: do not choose (c) as the primary move. Spend 30–60 days fixing claims and the cancellation flow, then pilot (a) with two hospitals and a co-branded pack whose copy is pre-approved. Set a six-month gate: pharmacy reorder rate, subscriber retention above 60%, and cancellation complaints below 3%. Defer Vietnam until the Thai unit has a compliant claims dossier and 12 months of stable retention.
3. Design a governance and measurement plan to fix the subscription cancellation issue and track trust. Name three KPIs with thresholds.
Read the worked answer
Governance. Create a cross-functional claims committee with regulatory, legal, marketing and product representation. Every claim and influencer script requires signed pre-approval against a substantiation file. For subscriptions, move to clear opt-in after the trial, provide one-click online cancellation, send a renewal reminder before charging, and run a monthly root-cause review of cancellation complaints.
Measurement. Track complaint reasons, not just counts, and audit a sample of calls each month. Report trust metrics to the board alongside revenue so growth is not bought with distrust.
Three KPIs with thresholds.
- Cancellation complaints: at or below 2% of subscribers within 90 days, down from 9%.
- 90-day subscriber retention: at least 60%.
- Claims compliance: 100% of live claims and influencer scripts pre-approved, verified by a monthly audit.
Add a quarterly trust tracker: at least 70% of customers agreeing that 'this brand is honest', and 95% of refunds resolved within five days. If the trust metric falls while revenue rises, the board should treat that as a leading indicator of regulatory and churn risk.